Clinical decision-making and documentation gaps associated with influenza antiviral treatment in hospitalized children

2026/01/01 by Christina B. Felsen, Erin Licherdell, Maria A. Gaitan +2 · 1 voice
Medicine · #Infectious Encephalopathies and Encephalitis #Influenza Virus Research Studies #Respiratory viral infections research

paper · pdf · doi:10.1017/ash.2026.10791

openalex publication_date 2026/01/01 · openalex created_date 2026/07/23 · openalex updated_date 2026/08/01

Abstract

Influenza antivirals are recommended for all hospitalized children. During 2023-2024, only 42% of hospitalized children with influenza in 7 counties in Western NY were treated. Comorbidities, illness severity, and symptoms predicted treatment. Parental declination, emphasis of treatment risk, and providers' application of outpatient guidelines to inpatients also played a role.

Citations

• A Step-by-Step Process of Thematic Analysis to Develop a Conceptual Model in Qualitative Research
• Impact of a physician recommendation on COVID-19 vaccination intent among vaccine hesitant individuals
• Documentation of antimicrobial indication and duration in electronic health records in a rehabilitation hospital: a cross-sectional study

Discussions

• During 2023-2024, only 42% of hospitalized children with influenza in Western, NY received antivirals. Comorbidities, illness severity, symptoms, and parent and provider factors such as applying outpa [bsky, 3 points, 1 comments]

Related

• Pediatric Antibiotic Use Associated With Respiratory Syncytial Virus and Influenza in the United States, 2008–2018
• Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021–2024
• Recommendations for Prevention and Control of Influenza in Children, 2025–2026: Technical Report
• Risk factors for re-hospitalization within 90 days of discharge for severe influenza in children
• Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023–2024